Tsu Ming Chien
Papers
1
Total Citations
3
H-Index
1
About
Dr. Tsu Ming Chien is a urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly those undergoing radical prostatectomy. His major contributions center on understanding the clinical significance of positive surgical margins (PSMs) and their role in biochemical recurrence (BCR). In his most cited work, Dr. Chien conducted a rigorous cohort analysis of 111 patients, evaluating the effectiveness of adjuvant therapy in managing BCR risk following surgery. This study provides critical insights for tailoring postoperative treatment strategies, helping to reduce recurrence rates and improve long-term survival. With 3 citations to date, this paper is gaining traction among clinicians and researchers seeking evidence-based approaches to prostate cancer management. Dr. Chien’s work bridges the gap between surgical pathology and adjuvant therapeutics, offering practical guidance for personalized care. His research is particularly valuable for students and clinicians navigating the complexities of prostate cancer recurrence, as it highlights the importance of margin status in treatment decision-making. Through his focused investigations, Dr. Chien is contributing to a deeper understanding of how to optimize outcomes for high-risk patients.
Research Focus
Key Achievements
Top Papers
- 1